The Nerve Repair And Regenerative Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Nerve Repair And Regenerative Market:
https://www.thebusinessresearchcompany.com/report/nerve-repair-and-regenerative-global-market-report
According to The Business Research Company’s Nerve Repair And Regenerative Global Market Report 2024, The nerve repair and regenerative market size has grown rapidly in recent years. It will grow from $8.96 billion in 2023 to $9.9 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased incidence of nerve injuries, aging population and neurodegenerative diseases, rise in peripheral nerve surgeries, growth in awareness and diagnosis rates, patient preferences for minimally invasive procedures.
The nerve repair and regenerative market size is expected to see rapid growth in the next few years. It will grow to $14.98 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to focus on stem cell therapies, increase in sports-related nerve injuries, development of gene therapy approaches, government initiatives for rare diseases, patient-centric healthcare models. Major trends in the forecast period include advancements in neurostimulation technologies, use of stem cells for nerve regeneration, nanotechnology in nerve repair, collaborations and partnerships, integration of bioengineering and robotics.
The increasing incidences of neurological disorders are expected to propel the growth of the nerve repair and regenerative market going forward. Neurological disorder refers to a condition or disease that affects the structure or function of the nervous system, including the brain, spinal cord, and peripheral nerves. The increasing incidences of neurological disorders are mostly driven by the growing aging population, changes in lifestyle, genetic factors, and lack of physical activity, where nerve repair and regenerative techniques aim to facilitate the healing and regeneration of damaged nerves, enhancing the chances of recovery and reducing incidences of neurological disorders, thus contributing to the growth of the nerve repair and regenerative market. For instance, in February 2023, according to a report released by the World Health Organization (WHO), a United Nations Agency, epilepsy is recognized as one of the most prevalent neurological disorders on a global scale. The report suggests that more than 50 million individuals worldwide are affected by epilepsy, a neurological disorder characterized by recurrent seizures, indicating its widespread impact. Notably, approximately 80% of people diagnosed with epilepsy reside in low- and middle-income countries. Therefore, the increasing incidences of neurological disorders is driving the growth of the nerve repair and regenerative market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=12093&type=smp
The nerve repair and regenerative market covered in this report is segmented –
1) By Product: Biomaterials, Neurostimulation And Neuromodulation Devices
2) By Application: Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy, Neurostimulation And Neuromodulation Surgeries, Other Applications
3) By End-Users: Hospitals And Clinics, Ambulatory Surgical Centers (ASCs), Research And Academic Institutions, Specialty Clinics, Other End-Users
Product innovation has emerged as a key trend gaining popularity in the nerve repair and regenerative market. Major market players are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in August 2022, Abbott, a US-based medical device company received United States FDA approval for ProClaim plus spinal cord stimulation system featuring FlexBurst therapy. It is designed to provide relief for individuals experiencing chronic pain associated with various conditions, including certain nerve-related disorders. The ProClaim Plus system offers the advantage of treating multi-site pain and thus physicians can target multiple pain sites to address the complex pain patterns associated with certain neuro disorders. This approval signifies an advancement in the field of pain management and aims to enhance the quality of life by reducing pain and improving overall well-being.
The nerve repair and regenerative market report table of contents includes:
Executive Summary
Nerve Repair And Regenerative Market Characteristics
Nerve Repair And Regenerative Market Trends And Strategies
Nerve Repair And Regenerative Market - Macro Economic Scenario
Global Nerve Repair And Regenerative Market Size and Growth
.
.
.
Global Nerve Repair And Regenerative Market Competitive Benchmarking
Global Nerve Repair And Regenerative Market Competitive Dashboard
Key Mergers And Acquisitions In The Nerve Repair And Regenerative Market
Nerve Repair And Regenerative Market Future Outlook and Potential Analysis
Appendix
Top 5 Major Key Players Are:
Neuronetics Inc
Abbott Laboratories
Medtronic PLC
Stryker Corporation
Baxter International Inc
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email:
[email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model